|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - LA JOLLA PHARMACEUTICAL CO (LJPC)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-08-16 Purchase |
2018-08-20 9:06 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
1,000 | $22 | $21,997 | 74,328 (Direct) |
View |
| 2018-08-16 Purchase |
2018-08-20 9:05 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
1,000 | $20.9 | $20,895 | 6,500 (Direct) |
View |
| 2018-03-15 Purchase |
2018-03-26 4:59 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
700,000 | $29.5 | $20,650,000 | 4,313,611 (Indirect) |
View |
| 2018-03-15 Purchase |
2018-03-19 8:15 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director, 10% Owner |
508,474 | $29.5 | $14,999,983 | 4,138,893 (Indirect) |
View |
| 2018-03-02 Purchase |
2018-03-02 5:56 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director, 10% Owner |
40,000 | $30.06 | $1,202,527 | 3,630,419 (Indirect) |
View |
| 2018-02-23 Purchase |
2018-02-27 9:00 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
1,000 | $32.47 | $32,475 | 5,500 (Direct) |
View |
| 2018-02-23 Purchase |
2018-02-27 4:50 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director, 10% Owner |
150,000 | $31.82 | $4,772,334 | 3,590,419 (Indirect) |
View |
| 2018-02-15 Purchase |
2018-02-20 4:19 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
50,000 | $32.42 | $1,621,000 | 3,613,611 (Indirect) |
View |
| 2018-02-13 Purchase |
2018-02-15 4:17 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
175,000 | $32.72 | $5,725,250 | 3,563,611 (Indirect) |
View |
| 2017-12-29 Sale |
2018-01-03 9:55 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
10,000 | $32.32 | $323,208 | 14,000 (Direct) |
View |
| 2017-12-27 Purchase |
2017-12-29 5:07 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
1,000 | $33.22 | $33,215 | 4,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-11-30 Option Award |
2018-12-03 9:57 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
26 | $12.3 | 594 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:57 pm |
N/A 2028-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
26 | $14.47 | 594 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:56 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
63 | $12.3 | 74,563 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:56 pm |
N/A 2028-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
63 | $14.47 | 74,563 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:56 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
100 | $12.3 | 1,281,060 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:56 pm |
N/A 2028-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
100 | $14.47 | 1,281,060 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:56 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
16 | $12.3 | 2,147 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:56 pm |
N/A 2028-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
16 | $14.47 | 2,147 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:55 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
96 | $12.3 | 6,860 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-03 9:55 pm |
N/A 2028-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
96 | $14.47 | 6,860 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:06 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
97 | $12.66 | 1,280,960 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:06 pm |
N/A 2028-11-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
97 | $14.9 | 1,280,960 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:06 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
61 | $12.66 | 74,500 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:06 pm |
N/A 2028-11-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
61 | $14.9 | 74,500 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
24 | $12.66 | 568 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:05 pm |
N/A 2028-11-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
24 | $14.9 | 568 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
94 | $12.66 | 6,764 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:05 pm |
N/A 2028-11-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
94 | $14.9 | 6,764 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:04 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
16 | $12.66 | 2,131 (Direct) |
View |
| 2018-11-15 Option Award |
2018-11-19 5:04 pm |
N/A 2028-11-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
16 | $14.9 | 2,131 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:43 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
56 | $13.85 | 74,439 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:43 pm |
N/A 2028-10-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
56 | $16.3 | 74,439 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:42 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
85 | $13.85 | 6,670 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:42 pm |
N/A 2028-10-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
85 | $16.3 | 6,670 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:42 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
15 | $13.85 | 2,115 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:42 pm |
N/A 2028-10-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
15 | $16.3 | 2,115 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:41 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
89 | $13.85 | 1,280,863 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:41 pm |
N/A 2028-10-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
89 | $16.3 | 1,280,863 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:40 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
22 | $13.85 | 544 (Direct) |
View |
| 2018-10-31 Option Award |
2018-11-01 8:40 pm |
N/A 2028-10-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
22 | $16.3 | 544 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:53 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
22 | $13.81 | 522 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:53 pm |
N/A 2028-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
22 | $16.25 | 522 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:53 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
15 | $13.81 | 2,100 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:53 pm |
N/A 2028-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
15 | $16.25 | 2,100 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:52 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
55 | $13.81 | 74,383 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:52 pm |
N/A 2028-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
55 | $16.25 | 74,383 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:52 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
88 | $13.81 | 1,280,774 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:52 pm |
N/A 2028-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
88 | $16.25 | 1,280,774 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:51 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
85 | $13.81 | 6,585 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-15 8:51 pm |
N/A 2028-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
85 | $16.25 | 6,585 (Direct) |
View |
| 2018-05-30 Exercise |
2018-06-01 9:12 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
500 | $6 | 13,500 (Direct) |
View |
| 2018-05-30 Exercise |
2018-06-01 9:12 pm |
N/A 2023-11-21 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
500 | $6 | 13,500 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 9:55 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
6,000 | $10.84 | 14,000 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 9:55 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
4,000 | $6 | 14,000 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 9:55 pm |
N/A 2024-04-03 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
6,000 | $10.84 | 14,000 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 9:55 pm |
N/A 2023-11-21 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Douglass Laura L. Director |
4,000 | $6 | 14,000 (Direct) |
View |
| 2017-12-27 Option Award |
2017-12-29 5:04 pm |
N/A 2027-12-27 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
6,700 | $32.47 | 6,700 (Direct) |
View |
| 2017-12-27 Option Award |
2017-12-29 5:04 pm |
N/A 2027-12-27 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
6,700 | $32.47 | 6,700 (Direct) |
View |
| 2017-12-27 Option Award |
2017-12-29 5:04 pm |
N/A 2027-12-27 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
6,700 | $32.47 | 6,700 (Direct) |
View |
| 2017-12-27 Option Award |
2017-12-29 5:04 pm |
N/A 2027-12-27 |
LA JOLLA PHARMACEUTICAL CO | LJPC | TIDMARSH GEORGE F CEO |
25,000 | $32.47 | 25,000 (Direct) |
View |
| 2017-12-27 Option Award |
2017-12-29 5:03 pm |
N/A 2027-12-27 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
6,700 | $32.47 | 6,700 (Direct) |
View |
| 2017-12-11 Option Award |
2017-12-13 9:07 pm |
N/A 2027-12-11 |
LA JOLLA PHARMACEUTICAL CO | LJPC | CARVER JENNIFER COO |
49,000 | $28.1 | 49,000 (Direct) |
View |
| 2017-12-11 Option Award |
2017-12-13 9:07 pm |
N/A 2027-12-11 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO |
49,000 | $28.1 | 49,000 (Direct) |
View |
| 2017-12-11 Option Award |
2017-12-13 9:06 pm |
N/A 2027-12-11 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director |
10,000 | $28.1 | 10,000 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Sat, 15 Dec 2018 10:07:24 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |